Treatment Adherence clinical trials at UCSF
2 research studies open to eligible people
Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
open to eligible people ages 18 years and up
The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.
San Francisco, California
Strategies for Improving Linkage-to-Care After Eye Disease Screening
open to eligible people ages 60 years and up
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
San Francisco, California
Our lead scientists for Treatment Adherence research studies include Sriranjani Padmanabhan Jeremy Keenan, MD, MPH.